Vytorin Tablet
NDC Package 78206-175-01
Package Information
Vytorin (ezetimibe and simvastatin) tablets is vYTORINVYTORIN® is a combination of simvastatin and ezetimibe indicated:As an adjunct to diet to reduce elevated low density lipoprotein cholesterol (LDL-C):In adults with primary hyperlipidemia.In adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH).As an adjunct to other LDL-C-lowering therapies to reduce elevated LDL-C in adults with homozygous familial hypercholesterolemia (HoFH).SimvastatinSimvastatin, when used as a component of VYTORIN, is indicated to reduce the risk of total mortality by reducing risk of coronary heart disease death, non-fatal myocardial infarction and stroke, and the need for coronary and non-coronary revascularization procedures in adults with established coronary heart disease, cerebrovascular disease, peripheral vascular disease, and/or diabetes, who are at high risk of coronary heart disease events. This formulation utilizes a tablet delivery system. Marketed by Organon Llc, this product is identified by NDC 78206-175 and is authorized under FDA application NDA021687.
Identification & Billing
- RxCUI: 1245420 - Vytorin 10 MG / 10 MG Oral Tablet
- RxCUI: 1245420 - ezetimibe 10 MG / simvastatin 10 MG Oral Tablet [Vytorin]
- RxCUI: 1245420 - Vytorin 10/10 (ezetimibe 10 MG / simvastatin 10 MG) Oral Tablet
- RxCUI: 1245420 - Vytorin 10/10 Oral Tablet
- RxCUI: 1245430 - Vytorin 10 MG / 20 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 78206 - Organon Llc
- 78206-175 - Vytorin
- 78206-175-01 - 30 TABLET in 1 BOTTLE
- 78206-175 - Vytorin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (78206-175). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 78206-175-01 identifies a specific commercial package of 30 tablet in 1 bottle of Vytorin, a human prescription drug labeled by Organon Llc. This tablet is formulated for oral use and contains ezetimibe; simvastatin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Organon Llc on June 01, 2021. The current certification is valid through December 31, 2027.
How is this Organon Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 78206017501. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.